| Catalog No. |
TD-MX139016 |
| Species reactivity |
Human |
| Applications |
Research Grade Biosimilar |
| Host species |
Mouse |
| Isotype |
IgG2a-kappa |
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
T1, DER4, Interleukin-1 receptor-like 1, ST2, IL1RL1, Protein ST2 |
| Endotoxin level |
Please contact with the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G, purified from cell culture supernatant. |
| Accession |
Q01638 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS,pH7.4. |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names |
AMG-282, MSTT-1041A, RG-6149, RO-7187807, CAS: 2173054-79-8 |
| Background |
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research. |
| Note |
For research use only. |